MMedication Read More Hims & Hers abandons plan for cheaper Wegovy knockoff after FDA warningMarch 11, 2026 Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy…
MMedication Read More Hims & Hers will sell real Ozempic in deal with Novo NordiskMarch 11, 2026 Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will…
MMedication Read More The era of $199 copycat weight loss drugs is ending — and it could cost patientsMarch 10, 2026 After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…
MMedication Read More The most controversial Super Bowl ad of 2025 is back for moreFebruary 7, 2026 Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…
MMedication Read More Hims and Hers Health’s compounded Wegovy pill offering fuels market jittersFebruary 6, 2026 Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
MMedication Read More Hims and Hers Health’s compounded Wegovy pill offering fuels market jittersFebruary 5, 2026 Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
MMedication Read More Hims launches $49 compounded copy of Wegovy weight-loss pillFebruary 5, 2026 By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…
MMedication Read More Is Regulatory Scrutiny and Novo Nordisk Partnership Loss Changing the Investment Case for Hims & Hers Health (HIMS)?August 25, 2025 Hims & Hers Health is facing a securities class action lawsuit following the past termination of its partnership…